Corporate Updates

Ipca Labs arm acquires 80 percent stake in Bayshore Pharmaceuticals

Views: 469

Ipca LabsPharmaceutical firm Ipca Laboratories on Wednesday announced the acquisition of 80 per cent stake in US’ Bayshore Pharmaceuticals LLC by its subsidiary for $10.286 million (approx Rs 75.4 crore).

In a regulatory filing, Ipca Laboratories said the endeavour will help the company to commercialise its registered generics drug products in the US market through this entity.

 “The company’s wholly-owned subsidiary, Ipca Pharmaceuticals Inc., USA, has acquired, on October 2, 2018, 80 per cent share capital of Bayshore Pharmaceuticals LLC, a New Jersey limited liability company …for cash $10.286 million,” it added.

For its financial year ended December 31, 2017, Bayshore had a total income of $7.05 million.

 

 

 

Recommended from all portals

Latest News

To Top